Intracavernosal etilefrine self-injection therapy for recurrent priapism: one decade of follow-up.
Recurrent idiopathic priapism is a rare condition that, if not properly treated, may lead to impaired quality of life and erectile dysfunction. Treatment can be achieved by prevention of priapism episodes with systemic therapy or by early intervention with intracavernosal self-injection of sympathomimetic agents. We describe a case of a young patient with recurrent idiopathic priapism who has used etilefrine self-injection for the past 10 years with good efficacy and libido and erectile function preservation. This report suggests that this approach may be safely indicated in selected cases, particularly when sexual function preservation is a major concern.
Teloken
Claudio
C
Division of Urology, Department of Surgery, Federal Foundation of Medical Sciences of Porto Alegre, Porto Alegre, Brazil.
Ribeiro
Eduardo Porto
EP
Chammas
Mário
M
Teloken
Patrick E
PE
Souto
Carlos Ary Vargas
CA
D000328:Adult; D005039:Etilefrine / Q000008:administration & dosage*; D006801:Humans; D007267:Injections; D008297:Male; D010413:Penis; D011317:Priapism / Q000188:drug therapy*; D012008:Recurrence; D012646:Self Administration; D013566:Sympathomimetics / Q000008:administration & dosage*
D013566:Sympathomimetics; D005039:Etilefrine